Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
Insider CIK 1787092 · FMTX 10% owner · NRIX 10% owner · PMVP · BDTX 10% owner · EWTX 10% owner · GBIO 10% owner · OLMA 10% owner · ACRV 10% owner · BOLD 10% owner · ALGS 10% owner · KYMR 10% owner · ARTV 10% owner · DYN 10% owner · VERV 10% owner · NUVL 10% owner · ZBIO 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ZBIO Zenas BioPharma, Inc. | C Conversion deriv | 2024-09-16 | 2024-09-18 | 3,649,263 | — | $0 | 0 | SEC↗ |
| ZBIO Zenas BioPharma, Inc. | C Conversion deriv | 2024-09-16 | 2024-09-18 | 1,742,858 | — | $0 | 0 | SEC↗ |
| ZBIO Zenas BioPharma, Inc. | C Conversion deriv | 2024-09-16 | 2024-09-18 | 1,568,480 | — | $0 | 0 | SEC↗ |
| ZBIO Zenas BioPharma, Inc. | C Conversion | 2024-09-16 | 2024-09-18 | 200,718 | — | $0 | 801,624 | SEC↗ |
| ZBIO Zenas BioPharma, Inc. | C Conversion | 2024-09-16 | 2024-09-18 | 180,635 | — | $0 | 180,635 | SEC↗ |
| ZBIO Zenas BioPharma, Inc. | C Conversion | 2024-09-16 | 2024-09-18 | 420,271 | — | $0 | 600,906 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | C Conversion deriv | 2024-07-22 | 2024-07-22 | 145,089 | — | $0 | 0 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | C Conversion | 2024-07-22 | 2024-07-22 | 145,089 | — | $0 | 145,089 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | J Other | 2024-07-22 | 2024-07-22 | 49,019 | $10.20 | $500.0K | 194,108 | SEC↗ |
| BOLD Boundless Bio, Inc. | C Conversion deriv | 2024-04-02 | 2024-04-02 | 3,703,704 | — | $0 | 0 | SEC↗ |
| BOLD Boundless Bio, Inc. | C Conversion deriv | 2024-04-02 | 2024-04-02 | 7,142,857 | — | $0 | 0 | SEC↗ |
| BOLD Boundless Bio, Inc. | C Conversion | 2024-04-02 | 2024-04-02 | 189,933 | — | $0 | 189,933 | SEC↗ |
| BOLD Boundless Bio, Inc. | C Conversion | 2024-04-02 | 2024-04-02 | 366,300 | — | $0 | 556,233 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | C Conversion deriv | 2022-11-17 | 2022-11-21 | 2,190,131 | — | $0 | 0 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | C Conversion | 2022-11-17 | 2022-11-21 | 888,130 | — | $0 | 888,130 | SEC↗ |
| NUVL Nuvalent, Inc. | C Conversion deriv | 2021-08-02 | 2021-08-03 | 4,831,384 | — | $0 | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | C Conversion | 2021-08-02 | 2021-08-03 | 897,671 | — | $0 | 897,671 | SEC↗ |
| VERV Verve Therapeutics, Inc. | C Conversion deriv | 2021-06-21 | 2021-06-22 | 10,671,482 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | C Conversion deriv | 2021-06-21 | 2021-06-22 | 12,436,264 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | C Conversion | 2021-06-21 | 2021-06-22 | 1,152,490 | — | $0 | 2,495,571 | SEC↗ |
| VERV Verve Therapeutics, Inc. | C Conversion | 2021-06-21 | 2021-06-22 | 1,343,081 | — | $0 | 1,343,081 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | C Conversion deriv | 2021-03-30 | 2021-03-30 | 681,812 | — | $0 | 0 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | C Conversion | 2021-03-30 | 2021-03-30 | 681,812 | — | $0 | 681,812 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | C Conversion deriv | 2020-11-23 | 2020-11-24 | 451,986 | — | $0 | 0 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | C Conversion deriv | 2020-11-23 | 2020-11-24 | 1,273,420 | — | $0 | 0 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | C Conversion | 2020-11-23 | 2020-11-24 | 1,273,420 | — | $0 | 1,273,420 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | C Conversion | 2020-11-23 | 2020-11-24 | 451,986 | — | $0 | 1,725,406 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion deriv | 2020-10-20 | 2020-10-22 | 1,335,048 | — | $0 | 0 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion deriv | 2020-10-20 | 2020-10-22 | 571,143 | — | $0 | 0 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion | 2020-10-20 | 2020-10-22 | 1,335,048 | — | $0 | 1,335,048 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion | 2020-10-20 | 2020-10-22 | 571,143 | — | $0 | 1,906,191 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | C Conversion deriv | 2020-09-29 | 2020-09-29 | 760,267 | — | $0 | 0 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | C Conversion | 2020-09-29 | 2020-09-29 | 760,267 | — | $0 | 760,267 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | C Conversion deriv | 2020-09-21 | 2020-09-23 | 5,336,179 | — | $0 | 0 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | C Conversion | 2020-09-21 | 2020-09-23 | 1,608,785 | — | $0 | 1,608,785 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | C Conversion deriv | 2020-08-25 | 2020-08-27 | 1,529,847 | — | $0 | 0 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | C Conversion | 2020-08-25 | 2020-08-27 | 959,211 | — | $0 | 959,211 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-30 | 784,313 | — | $0 | 0 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-30 | 784,313 | — | $0 | 784,313 | SEC↗ |
| FMTX Forma Therapeutics Holding | C Conversion deriv | 2020-06-23 | 2020-06-25 | 5,359,344 | — | $0 | 0 | SEC↗ |
| FMTX Forma Therapeutics Holding | P Buy | 2020-06-23 | 2020-06-25 | 1,000,000 | $20.00 | $20.00M | 2,252,913 | SEC↗ |
| FMTX Forma Therapeutics Holding | C Conversion | 2020-06-23 | 2020-06-25 | 1,252,913 | — | $0 | 1,252,913 | SEC↗ |
| GBIO Generation Bio Co. | C Conversion deriv | 2020-06-16 | 2020-06-18 | 1,788,460 | — | $0 | 0 | SEC↗ |
| GBIO Generation Bio Co. | C Conversion | 2020-06-16 | 2020-06-18 | 1,012,546 | — | $0 | 1,012,546 | SEC↗ |
| GBIO Generation Bio Co. | P Buy | 2020-06-16 | 2020-06-18 | 1,100,000 | $19.00 | $20.90M | 2,112,546 | SEC↗ |
| BDTX Black Diamond Therapeutics | C Conversion deriv | 2020-02-03 | 2020-02-05 | 1,713,541 | — | $0 | 0 | SEC↗ |
| BDTX Black Diamond Therapeutics | C Conversion | 2020-02-03 | 2020-02-05 | 568,185 | — | $0 | 568,185 | SEC↗ |